BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10515103)

  • 1. Delayed reaction to oral treatment with clindamycin.
    Vicente J; Fontela JL
    Contact Dermatitis; 1999 Oct; 41(4):221. PubMed ID: 10515103
    [No Abstract]   [Full Text] [Related]  

  • 2. Clindamycin skin testing has limited diagnostic potential.
    Notman MJ; Phillips EJ; Knowles SR; Weber EA; Shear NH
    Contact Dermatitis; 2005 Dec; 53(6):335-8. PubMed ID: 16364122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of patch testing for the diagnosis of delayed-type drug hypersensitivity reactions to clindamycin.
    Gilissen L; Huygens S; Goossens A; Breynaert C; Schrijvers R
    Contact Dermatitis; 2020 Sep; 83(3):237-239. PubMed ID: 32333605
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous adverse reactions to clindamycin: results of skin tests and oral exposure.
    Lammintausta K; Tokola R; Kalimo K
    Br J Dermatol; 2002 Apr; 146(4):643-8. PubMed ID: 11966697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clindamycin-associated acute generalized exanthematous pustulosis.
    Valois M; Phillips EJ; Shear NH; Knowles SR
    Contact Dermatitis; 2003 Mar; 48(3):169. PubMed ID: 12755740
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of patch tests in clindamycin-related drug eruptions.
    Pereira N; Canelas MM; Santiago F; Brites MM; Gonçalo M
    Contact Dermatitis; 2011 Oct; 65(4):202-7. PubMed ID: 21689110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing.
    El Khoury M; Assier H; Gener G; Paul M; Haddad C; Chosidow O; Wolkenstein P; Ingen-Housz-Oro S
    Br J Dermatol; 2018 Oct; 179(4):978-979. PubMed ID: 29747236
    [No Abstract]   [Full Text] [Related]  

  • 9. SDRIFE-like reaction induced by an intradermal skin test with clindamycin: A case report.
    Morales-Cabeza C; Caralli Bonett ME; Micozzi S; Seoane Rodríguez M; Rojas-Pérez-Ezquerra P; de Barrio Fernández M
    J Allergy Clin Immunol Pract; 2015; 3(6):976-7. PubMed ID: 26164811
    [No Abstract]   [Full Text] [Related]  

  • 10. Patch testing for evaluating drug reactions due to systemic antibiotics.
    Cham PM; Warshaw EM
    Dermatitis; 2007 Jun; 18(2):63-77. PubMed ID: 17498411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-fatal delayed hypersensitivity reaction to cloxacillin.
    Moreno-Ancillo A; Domínguez-Noche C; Gil-Adrados AC; Cosmes PM
    Contact Dermatitis; 2003 Jul; 49(1):44-5. PubMed ID: 14641124
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute generalized exanthematous pustulosis with histopathologic findings of lymphomatoid drug reaction.
    Llamas-Velasco M; Godoy A; Sánchez-Pérez J; García-Diez A; Fraga J
    Am J Dermatopathol; 2013 Aug; 35(6):690-1. PubMed ID: 23291582
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic allergic dermatitis resulting from oral administration of chromium with a food supplement.
    De Marchi S; Cecchin E; De Marchi SU
    Contact Dermatitis; 2014 Feb; 70(2):123-5. PubMed ID: 24450828
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug rash with eosinophilia and systemic symptoms syndrome associated with clindamycin.
    Tian D; Mohan RJ; Stallings G
    Am J Med; 2010 Nov; 123(11):e7-8. PubMed ID: 20843501
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced hypersensitivity syndrome induced by clindamycin.
    Nakamura Y; Watamatsu K; Muto M
    Acta Derm Venereol; 2013 Jan; 93(1):83-4. PubMed ID: 22855006
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitization to ephedrine in oral anticatarrhal drugs.
    Audicana M; Urrutia I; Echechipia S; Muñoz D; Fernández de Corres L
    Contact Dermatitis; 1991 Mar; 24(3):223. PubMed ID: 1831099
    [No Abstract]   [Full Text] [Related]  

  • 17. Rash from oral codeine.
    van Ketel WG
    Contact Dermatitis; 1986 Sep; 15(3):195. PubMed ID: 2946544
    [No Abstract]   [Full Text] [Related]  

  • 18. Fixed drug eruption due to clindamycin with tolerance to lincomycin.
    Romero-Sánchez L; Méndez-Brea P
    Contact Dermatitis; 2022 Oct; 87(4):369-370. PubMed ID: 35608453
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed hypersensitivity to flurbiprofen.
    Romano A; Pietrantonio F
    J Intern Med; 1997 Jan; 241(1):81-3. PubMed ID: 9042097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of cutaneous delayed-type allergy to oral dexamethasone and to betamethasone.
    Nucera E; Buonomo A; Pollastrini E; De Pasquale T; Del Ninno M; Roncallo C; Schiavino D; Patriarca G
    Dermatology; 2002; 204(3):248-50. PubMed ID: 12037457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.